PTPRC and thromboangiitis obliterans: Compared to inactive TAO, and normal control (NC) groups, it was observed that the CD22-PTPRC interaction between Bregs and cDC1s, cDC2s, IMOs, NMOs, or CMOs were significantly stronger in active TAO patients (Figure 7B).